IP Library Granted Patent US 9,988,349
Granted Patent B2
US 9,988,349 · App. 15/109,396 · Granted Jun 5, 2018

Direct stereospecific synthesis of unprotected aziridines from olefins

Inventors: Daniel Halsell Ess (Provo, UT); John Russell Falck (University Park, TX); Jawahar Lal Jat (Rajasthan, IN); Laszlo Kurti (Dallas, TX)
C07D203/02B01J31/2208C07D203/08B01J2231/321B01J2531/16B01J2531/822
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,349
App. No.
15/109,396
Granted
Jun 5, 2018
Kind
B2
Abstract

A method for the direct stereospecific conversion of structurally diverse mono-, di-, tri- and tetra-substituted olefins to N—H, N-alkyl, N-cycloalkyl, or N-aralkyl aziridines using a hydroxylamine amination agent with transition metal catalyst. The method is operationally simple (i.e., one-pot), scalable and fast at ambient temperature.

Claims (38)

1. A process for making an aziridine of the formula AP-1

where R 1A is selected from H, unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, and aralkyl;

each of R a , R b , R c , and R d is independently selected from: H, substituted and unsubstituted aryl, unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, C 2 -C 18 alkenyl, C 3 -C 8 cycloalkenyl, and C 2 -C 18 alkenyl, or wherein R c and R d form a ring;

the method comprising:

reacting an olefin of formula O-1

with a hydroxylamine amination agent in the presence of a transition metal catalyst selected from copper and rhodium catalysts in a polar, hydroxylic and non-nucleophilic solvent, a carboxylic solvent or mixtures of the same at a temperature less than 30° C.;

wherein the hydroxylamine amination agent is selected from compounds of formulas AA-1, AA-2, AA-5, AA-6, AA-7, AA-8:

wherein each R 1 and R 2 are independently selected from hydrogen, unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, —Si(R 3 ) 3 , allyl, aralkyl, substituted and unsubstituted aryl, and substituted and unsubstituted heteroaryl;

wherein R 1 and R 2 can be connected to form a cyclic amine having from 4 to 7 carbocyclic ring members;

each R 3 is independently selected from unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro and substituted or unsubstituted aryl;

each R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from hydrogen, nitro, fluoro, chloro, bromo, unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N + —, and (R 20 ) 2 P(O)—;

R 9 is selected from unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, and C 3 -C 8 cycloalkyl;

R 10 and R 11 are independently selected from substituted and unsubstituted aryl;

wherein the number of substituents for substituted aryl may be from 1 to 5 and independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N + , (R 20 ) 2 P(O)—, PEG m -, and o-furanyl;

R 12 is selected from unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, C 1 -C 18 alkenyl, C 3 -C 8 cycloalkenyl, substituted and unsubstituted aryl;

wherein the number of substituents for substituted aryl may be from 1 to 5 and independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N + —, (R 20 ) 2 P(O)—, PEG m -, and o-furanyl;

R 13 is selected from substituted and unsubstituted aryl, substituted and unsubstituted heteroaryl, unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro, C 3 -C 8 cycloalkyl, and CCl 3 , or when R 13 forms an aromatic or other ring system with R 15 , then R 13 is selected from O, N, and C—R 20 ;

wherein the number of substituents for substituted aryl may be from 1 to 5 and wherein the number of substituents for substituted heteroaryl may be from 1 to 4 and each substituent is independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N+—, and (R 20 ) 2 P(O)—, PEG m -, and o-furanyl;

R 14 is absent or selected from H, substituted and unsubstituted aryl, C 3 -C 8 cycloalkyl, and unsubstituted C 1 -C 18 alkyl or C 1 -C 18 alkyl substituted with fluoro,

wherein the number of substituents for substituted aryl may be from 1 to 5 and wherein the number of substituents for substituted heteroaryl may be from 1 to 4 and each substituent is independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N + —, and (R 20 ) 2 P(O)—, PEG m -,

R 15 is selected from selected from substituted and unsubstituted aryl, unsubstituted C 1 -C 8 alkyl or C 1 -C 18 alkyl substituted with fluoro, and C 3 -C 8 cycloalkyl, or when R 15 forms an aromatic or other ring system with R 13 , then R 15 is CH or CH 2 ;

wherein the number of substituents for substituted aryl may be from 1 to 5 and each substituent is independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, R 16 R 17 NC(O)—, R 18 O 2 C—, (R 19 ) 4 N + —, and (R 20 ) 2 P(O)—, PEG m -,

where each m is independently from 1 to 6;

each R 16 , R 17 , R 18 , R 19 , R 20 is independently selected from H, C 3 -C 8 cycloalkyl, substituted and unsubstituted aryl, substituted and unsubstituted heteroaryl, and unsubstituted C 1 -C 18 alkyl and C 1 -C 18 alkyl substituted with fluoro;

wherein the number of substituents for each substituted aryl may be from 1 to 5 and the number of substituents for each substituted heteroaryl may be from 1 to 4 and each substituent is independently selected from nitro, fluoro, chloro, methyl, ethyl, isopropyl, tert-butyl, arylsulfonyl, alkylsulfonyl, mono-/di-/tri-fluoroalkylsulfonyl, trifluoromethyl, PEG m .

2. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-1.

3. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-2.

4. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-5.

5. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-6.

6. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-7.

7. The process of claim 1 , wherein the hydroxylamine amination agent is of formula AA-8.

8. The process of claim 1 , wherein the transition metal catalyst is a copper catalyst.

9. The process of claim 1 , wherein the transition metal catalyst is a rhodium catalyst.

10. The process of claim 1 , wherein the catalyst is selected from: Rh 2 (OAc) 4 , Rh 2 (octanoate) 4 , and Rh 2 (esp) 2 .

11. The process of claim 1 , wherein the polar, hydroxylic and nonnucleophilic solvent comprises trifluoroethanol.

12. The process of claim 1 , wherein the transition metal catalyst is incrementally introduced in batches of about 1 mol %.

13. The process of claim 1 , wherein R c and R d form a ring.

14. The process of claim 10 , wherein R c and R d form a ring.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 9, 2020
From: UT SOUTHWESTERN MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052121/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2018
From: FALCK, JOHN RUSSELL; KURTI, LASZLO; JAT, JAWAHAR LAL
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 047258/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2018
From: ESS, DANIEL HALSELL
To: BRIGHAM YOUNG UNIVERSITY
Reel/Frame 045885/0640 →
Continuity (2)
Provisional Application 61964375 · Jan 3, 2014
Related Publication 20160340305A1 · Nov 24, 2016